English
Français
Español
Deutsch
Italiano
العربية
November 17, 2025 Global Tour 2025 · Key Station for European Market Penetration
From November 17 to 20, the world-renowned MEDICA 2025 kicked off grandly in Düsseldorf, Germany. As the "barometer" of the global medical industry, this exhibition gathered over 6,000 exhibitors from 72 countries and regions, attracting more than 80,000 professional visitors worldwide. Vivolight Medical, a leader in China's minimally invasive laser medical devices, made a stunning appearance with its AI-empowered flagship products, becoming a highlight of the Chinese enterprise exhibition area and demonstrating the innovative strength of "Made-in-China" medical equipment on the global stage.
AI + Multimodal Imaging: P80 Redefines Cardiovascular Diagnosis Standards
Medica 2025 - The P80 multimodal cardiovascular OCT system, became the focus of on-site attention with its industry-leading technological configuration. As the first FDA-cleared mede-in-China OCT platform integrated with AI diagnosis , this system perfectly combines imaging (OCT), functional assessment (FFR), physiological evaluation and AI-guided analysis, creating a one-stop diagnostic workflow for interventional cardiologists.
Compared with the previous generation, the new P80 not only maintains the highest resolution imaging effect in the market but also realizes automatic identification of vascular lesions and quantitative analysis of stenosis through the built-in AI algorithm. This technological breakthrough not only does not increase the operational complexity but also further expands the depth of coronary disease diagnosis, setting a new industry benchmark.
Vascular Navigation Dual Star: Creating a New Paradigm for Precision Puncture
Targeting the pain points of vessel puncture in clinical practice, Vivolight Medical brought two star products of vascular navigation: the upgraded projection vein finder V800P and the world's first AR vascular navigation glasses Vglasses, which won wide attention from European medical institutions.
As a best-selling product in more than 90 countries and regions, the V800P has been fully optimized in multiple dimensions. Looking ahead, the company will launch a more powerful upgraded version, with its R&D direction deeply rooted in the practical needs of global medical staff collected on-site and through long-term cooperation. This upgrade will not only inherit the reliable performance of the existing V800P but also make targeted breakthroughs to better adapt to complex clinical scenarios, bringing more practical solutions to venous puncture work.
The Vglasses AR vascular navigation glasses, which attracted numerous on-site experiences, integrate augmented reality and infrared sensing technology innovatively. Medical staff can see the real-time vascular distribution image through the glasses, and adjust the diopter freely to adapt to different vision needs. A German emergency doctor who experienced the product said: "This kind of 'see-through' navigation method shortens the puncture time by nearly half, which is crucial for emergency rescue." This product not only reduces the risk of medical complications but also effectively improves patient comfort and treatment satisfaction.
Global Synergy: China's Innovation Connects the World
With the global layout continuing to deepen, Vivolight Medical's products have covered major markets such as the European Union, the United States, Brazil, and the Middle East. At this exhibition, the company's booth received a steady stream of visitors. Representatives from Germany, France, Spain and other countries had in-depth discussions on product clinical application scenarios, localized after-sales support, and joint R&D cooperation. Senior representatives of many global medical device giants also visited the booth to exchange views on technological innovation trends in the field of minimally invasive medicine .
Against the background that Chinese medical enterprises are accelerating their transformation from "followers" to "definers" , Vivolight Medical will continue to focus on technological innovation, deepen cooperation with global partners, and bring more high-quality medical device solutions to patients around the world, contributing Chinese strength to the development of global precision medicine.
IPv6 network supported